Insider · CIK 0001780854

BENZENO SHARON

Reports to the SEC for 1 company · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001780854

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-29	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Ofc Imm Med	SSale	−155K sh	$21.14	−$3.27M	221,278
2026-06-29	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	−1,837 sh	—	—	0
2026-06-29	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	+1,837 sh	$12.14	+$22.3K	274,588
2026-06-29	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	−24.9K sh	—	—	37,416
2026-06-29	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	+51.6K sh	$8.12	+$419K	376,046
2026-06-29	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	−24.9K sh	—	—	87,303
2026-06-29	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	+24.9K sh	$3.99	+$99.5K	324,476
2026-06-29	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	+24.9K sh	$8.46	+$211K	299,532
2026-06-29	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	−51.6K sh	—	—	113,457
2026-06-26	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Ofc Imm Med	SSale	−11K sh	$21.00	−$232K	272,751
2026-06-26	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	−11K sh	—	—	1,837
2026-06-26	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	+11K sh	$12.14	+$134K	283,785
2026-03-11	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Ofc Imm Med	SSale	−63.1K sh	$13.17	−$831K	272,751
2026-03-04	ADPTAdaptive Biotechnologies CorpA Award	Chief Commercial Ofc Imm Med	AAward	+39.1K sh	—	—	335,854
2025-12-04	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	+4,157 sh	$3.99	+$16.6K	309,395
2025-12-04	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Ofc Imm Med	SSale	−12.6K sh	$16.85	−$212K	296,791
2025-12-04	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	−4,157 sh	—	—	112,247
2025-12-04	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	+4,157 sh	$8.46	+$35.2K	305,238
2025-12-04	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	+4,290 sh	$12.14	+$52.1K	301,081
2025-12-04	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	−4,290 sh	—	—	12,871
2025-12-04	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	−4,157 sh	—	—	62,360
2025-11-21	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	−34.4K sh	—	—	0
2025-11-21	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	+20.8K sh	$6.55	+$136K	318,459
2025-11-21	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	−49.5K sh	—	—	0
2025-11-21	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	−120K sh	—	—	17,161
2025-11-21	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	+834 sh	$6.27	+$5,229.18	297,625
2025-11-21	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	+83.1K sh	$3.99	+$332K	605,268
2025-11-21	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	+49.5K sh	$6.55	+$324K	367,939
2025-11-21	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	+120K sh	$12.14	+$1.45M	522,123
2025-11-21	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	−834 sh	—	—	0
2025-11-21	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	−20.8K sh	—	—	0
2025-11-21	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	+34.4K sh	$7.27	+$250K	402,314
2025-11-21	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	−83.1K sh	—	—	116,404
2025-11-21	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Ofc Imm Med	SSale	−308K sh	$16.91	−$5.22M	296,791
2025-11-20	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Ofc Imm Med	SSale	−298K sh	$16.54	−$4.93M	296,791
2025-11-20	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	+69K sh	$12.14	+$837K	594,716
2025-11-20	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	+133K sh	$8.46	+$1.13M	525,755
2025-11-20	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	−133K sh	—	—	66,517
2025-11-20	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Ofc Imm Med	MExercise/Conversion	−69K sh	—	—	136,970
2025-03-05	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Ofc Imm Med	SSale	−41.6K sh	$6.98	−$290K	395,788
2025-03-05	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Ofc Imm Med	SSale	−3,065 sh	$6.99	−$21.4K	392,723
2025-03-04	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)A Award	Chief Commercial Ofc Imm Med	AAward	+165K sh	—	—	165,027
2025-03-04	ADPTAdaptive Biotechnologies CorpA Award	Chief Commercial Ofc Imm Med	AAward	+110K sh	—	—	437,388
2024-03-05	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Ofc Imm Med	SSale	−18.6K sh	$3.44	−$64.1K	327,415
2024-03-05	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Ofc Imm Med	SSale	−10.7K sh	$3.43	−$36.9K	346,059
2024-03-04	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)A Award	Chief Commercial Ofc Imm Med	AAward	+200K sh	—	—	199,549
2024-03-04	ADPTAdaptive Biotechnologies CorpA Award	Chief Commercial Ofc Imm Med	AAward	+133K sh	—	—	356,805
2023-03-06	ADPTAdaptive Biotechnologies CorpA Award	Chief Commercial Ofc Imm Med	AAward	+133K sh	—	—	235,575
2023-03-06	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Ofc Imm Med	SSale	−11.7K sh	$8.57	−$101K	223,826
2023-03-06	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)A Award	Chief Commercial Ofc Imm Med	AAward	+200K sh	—	—	199,549

Recent filings

Accepted (ET)
Jun 304
BENZENO SHARON0001780854-26-000008
SEC(opens sec.gov)
Mar 134
BENZENO SHARON0001780854-26-000004
SEC(opens sec.gov)
Mar 64
BENZENO SHARON0001780854-26-000002
SEC(opens sec.gov)
Dec 84
BENZENO SHARON0001780854-25-000003
SEC(opens sec.gov)

Companies

Adaptive Biotechnologies CorpChief Commercial Ofc Imm MedADPT

Address

C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1165 EASTLAKE AVENUE EAST

SEATTLE, WA, 98109